Clearside Biomedical, Inc. Common Stock (CLSD) EBITDA (2016 - 2025)
Clearside Biomedical, Inc. Common Stock (CLSD) EBITDA from Jun 30, 2016 to Sep 30, 2025. The TTM Clearside Biomedical, Inc. Common Stock (CLSD) EBITDA is -$20M. You can adjust inflation or export chart.
Annual EBITDA
Quarterly EBITDA
Clearside Biomedical, Inc. Common Stock (CLSD) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -23.99% |
| 3 Years TTM | +80.80% |
| 5 Years TTM | +7.59% |
| All Time TTM | -7.79% |
Annual EBITDA change of Clearside Biomedical, Inc. Common Stock (CLSD)
| Year | EBITDA | Change |
|---|---|---|
| 2025 | -$12M | -59.40% |
| 2024 | -$29M | +16.99% |
| 2023 | -$25M | -17.76% |
| 2022 | -$30M | +6595.56% |
| 2021 | -$450K | -97.46% |
| 2020 | -$18M | -41.01% |
| 2019 | -$30M | -63.64% |
| 2018 | -$83M | +42.13% |
| 2017 | -$58M | +131.72% |
| 2016 | -$25M | N/A |